Medical cannabis will likely become legal federally this decade so cannabis companies must establish brands that have strong consumer acceptance and name recognition to be well-positioned to roll out nationally when finally allowed to do so.

The munKNEE American Cannabis MSOs Index tracks the 12 largest vertically integrated (i.e. seed-to-sale) multi-state operators by market capitalization, and it fell 2.8% this week but remains + 0.6% YTD.

Our index of the 12 largest vertically integrated (i.e. seed-to-sale) multi-state operators by market capitalization fell 1.4% last week but is still up 3.5% YTD.

I am optimistic that the market will perform better in 2023 so I've put together a basket of 10 stocks that could well realize multi-bagger returns this year.

The Cannabis MSOs Index declined 42.6% in December, with multiple factors contributing significantly to the overall 72.7% decline in 2022.